Dépôts de vladikoff

An example application that demonstrates the use of Persona

Dernier commit 17 oct. 2013

Methodology and code supporting the BuzzFeed News/BBC article, "The Tennis Racket," published Jan. 17, 2016.

Dernier commit 17 janv. 2016

3d city builder

Dernier commit 11 juil. 2014

Efficient Augmented Reality for the Web - 60fps on mobile!

Dernier commit 22 août 2017

Dernier commit 21 oct. 2010

Android client SDK for communicating with OAuth 2.0 and OpenID Connect providers.

Dernier commit 2 mars 2018

🎮 GitHub ArchiveRoom - Explore your GitHub archive data in 3D!

Dernier commit 18 juil. 2014

RNA vaccines have become a key tool in moving forward through the challenges raised both in the current pandemic and in numerous other public health and medical challenges. With the rollout of vaccines for COVID-19, these synthetic mRNAs have become broadly distributed RNA species in numerous human populations. Despite their ubiquity, sequences are not always available for such RNAs. Standard methods facilitate such sequencing. In this note, we provide experimental sequence information for the RNA components of the initial Moderna (https://pubmed.ncbi.nlm.nih.gov/32756549/) and Pfizer/BioNTech (https://pubmed.ncbi.nlm.nih.gov/33301246/) COVID-19 vaccines, allowing a working assembly of the former and a confirmation of previously reported sequence information for the latter RNA. Sharing of sequence information for broadly used therapeutics has the benefit of allowing any researchers or clinicians using sequencing approaches to rapidly identify such sequences as therapeutic-derived rather than host or infectious in origin. For this work, RNAs were obtained as discards from the small portions of vaccine doses that remained in vials after immunization; such portions would have been required to be otherwise discarded and were analyzed under FDA authorization for research use. To obtain the small amounts of RNA needed for characterization, vaccine remnants were phenol-chloroform extracted using TRIzol Reagent (Invitrogen), with intactness assessed by Agilent 2100 Bioanalyzer before and after extraction. Although our analysis mainly focused on RNAs obtained as soon as possible following discard, we also analyzed samples which had been refrigerated (~4 ℃) for up to 42 days with and without the addition of EDTA. Interestingly a substantial fraction of the RNA remained intact in these preparations. We note that the formulation of the vaccines includes numerous key chemical components which are quite possibly unstable under these conditions-- so these data certainly do not suggest that the vaccine as a biological agent is stable. But it is of interest that chemical stability of RNA itself is not sufficient to preclude eventual development of vaccines with a much less involved cold-chain storage and transportation. For further analysis, the initial RNAs were fragmented by heating to 94℃, primed with a random hexamer-tailed adaptor, amplified through a template-switch protocol (Takara SMARTerer Stranded RNA-seq kit), and sequenced using a MiSeq instrument (Illumina) with paired end 78-per end sequencing. As a reference material in specific assays, we included RNA of known concentration and sequence (from bacteriophage MS2). From these data, we obtained partial information on strandedness and a set of segments that could be used for assembly. This was particularly useful for the Moderna vaccine, for which the original vaccine RNA sequence was not available at the time our study was carried out. Contigs encoding full-length spikes were assembled from the Moderna and Pfizer datasets. The Pfizer/BioNTech data [Figure 1] verified the reported sequence for that vaccine (https://berthub.eu/articles/posts/reverse-engineering-source-code-of-the-biontech-pfizer-vaccine/), while the Moderna sequence [Figure 2] could not be checked against a published reference. RNA preparations lacking dsRNA are desirable in generating vaccine formulations as these will minimize an otherwise dramatic biological (and nonspecific) response that vertebrates have to double stranded character in RNA (https://www.nature.com/articles/nrd.2017.243). In the sequence data that we analyzed, we found that the vast majority of reads were from the expected sense strand. In addition, the minority of antisense reads appeared different from sense reads in lacking the characteristic extensions expected from the template switching protocol. Examining only the reads with an evident template switch (as an indicator for strand-of-origin), we observed that both vaccines overwhelmingly yielded sense reads (>99.99%). Independent sequencing assays and other experimental measurements are ongoing and will be needed to determine whether this template-switched sense read fraction in the SmarterSeq protocol indeed represents the actual dsRNA content in the original material. This work provides an initial assessment of two RNAs that are now a part of the human ecosystem and that are likely to appear in numerous other high throughput RNA-seq studies in which a fraction of the individuals may have previously been vaccinated. ProtoAcknowledgements: Thanks to our colleagues for help and suggestions (Nimit Jain, Emily Greenwald, Lamia Wahba, William Wang, Amisha Kumar, Sameer Sundrani, David Lipman, Bijoyita Roy). Figure 1: Spike-encoding contig assembled from BioNTech/Pfizer BNT-162b2 vaccine. Although the full coding region is included, the nature of the methodology used for sequencing and assembly is such that the assembled contig could lack some sequence from the ends of the RNA. Within the assembled sequence, this hypothetical sequence shows a perfect match to the corresponding sequence from documents available online derived from manufacturer communications with the World Health Organization [as reported by https://berthub.eu/articles/posts/reverse-engineering-source-code-of-the-biontech-pfizer-vaccine/]. The 5’ end for the assembly matches the start site noted in these documents, while the read-based assembly lacks an interrupted polyA tail (A30(GCATATGACT)A70) that is expected to be present in the mRNA.

Dernier commit 24 mars 2021

Babylon.js: a complete JavaScript framework for building 3D games with HTML 5 and WebGL

Dernier commit 20 juil. 2013

This is a resurrection of a mechanism to allow web developers to flex their CSS capabilities working off of a common HTML file. Respect due to the folks that put together the CSS Zen Garden back in the day.

Dernier commit 23 juin 2012

The php WhatsApp library

Dernier commit 19 mai 2015

Dernier commit 18 juin 2014

Modify Android DEX/APK files at source-level using Java

Dernier commit 21 mars 2015

Testing GitHub Docs and etc...

Dernier commit 5 juil. 2012

Easy to maintain open source documentation websites.

Dernier commit 28 mars 2018

Find My Device (large server)

Dernier commit 22 juil. 2014

PoC used to exploit some Firefox vulnerabilities

Dernier commit 1 oct. 2013

FirefoxOS-Dropbox Example

Dernier commit 1 nov. 2014

Based on the EE 1.6.x extension for Freeform by Tim Kelty, this fieldtype pulls in field labels and names from Solspace's Freeform module. Now working with EE2.1, Matirx and Freeform 3.0.2

Dernier commit 24 août 2014

Infinite Scroll jQuery plugin + jQuery Masonry for Drupal

Dernier commit 15 janv. 2010